Patient Advocate Foundation Launches the Heart Valve CareLine, Providing Individualized Assistance to Patients Experiencing

   Patient Advocate Foundation Launches the Heart Valve CareLine, Providing
   Individualized Assistance to Patients Experiencing Challenges Accessing
                                  Healthcare

PR Newswire

HAMPTON, Va., March 25, 2013

The Heart Valve CareLine is now available toll-free to provide one-on-onecase
management support for patients diagnosed with heart valve conditions.

HAMPTON, Va., March 25, 2013 /PRNewswire-USNewswire/ -- Patient Advocate
Foundation (PAF), a national non-profit organization with extensive experience
in patient-focused case management, is pleased to launch the Heart Valve
CareLine as the newest addition to its MedCareLine division thanks to a
significant gift from The Edwards Lifesciences Fund. The Heart Valve CareLine
is a national, toll-free patient and provider hotline designed to provide free
healthcare information and crucial case management assistance for patients who
have been diagnosed with heart valve conditions. The dedicated hotline,
866-318-7892, is staffed by a team of professional case managers from PAF.

As the newest addition to PAF's MedCareLine program, the Heart Valve CareLine
provides customized assistance to support people diagnosed with valvular
conditions who are facing challenges with accessing the healthcare they need.
An American Heart Association survey of patients with cardiovascular disease
found that more than half had difficulties paying for medical care, even
though most had insurance, and 46 percent of those who had difficulty paying
their medical expenses said they had delayed getting necessary care.(a) PAF's
CareLine is staffed with case managers experienced in assisting patients
diagnosed with all types of heart valve conditions, and will provide help to
those facing access and financial challenges in their healthcare.The
individualized support services include assistance with insurance appeals,
insurance benefits and reimbursement, Medicare, Medicaid and Disability
screenings, enrollments and/or denials, options for addressing medical debt
crisis, as well as referrals to local, state or federal financial resources.

"Thanks to the generous commitment and support from The Edwards Lifesciences
Fund, which has resulted in this extension of our MedCareLine division, heart
valve patients now have a direct resource for their most complex issues and
will benefit from the guidance and expertise of the professional case managers
at Patient Advocate Foundation," stated PAF Founder and CEO Nancy
Davenport-Ennis.

"We are passionate about helping patients and have made this pursuit our
life's work," said Michael A. Mussallem, chairman and CEO of Edwards
Lifesciences. "By uniting with PAF to form the Heart Valve CareLine, we are
not only providing technologies to treat patients with valvular disease, but
we are also increasing access to the healthcare they need to live long,
high-quality lives."

Patients, caregivers and their providers can view a full list of services
available through the Heart Valve CareLine at HeartValve.pafcareline.org or
by calling the dedicated toll-free hotline at 866-318-7892. PAF's Heart
Valve CareLine case managers are available to assist Monday through Thursday
from 8:00 A.M. to 8:00 P.M. and Friday from 8:00 A.M. to 7:00 P.M. Eastern
Time.

About Patient Advocate Foundation (PAF):
PAF is a national non-profit organization, established in 1996, that seeks to
safeguard patients through effective mediation assuring access to care,
maintenance of employment and preservation of financial stability relative to
their diagnosis of chronic, life threatening or debilitating disease. Patient
Advocate Foundation has been consistently rated as a 4-star "exceptional"
charity by Charity Navigator, the foremost independent evaluator of charities
in the United States.For more information about Patient Advocate Foundation,
please visit www.patientadvocate.org.

About Edwards Lifesciences and The Edwards Lifesciences Fund:
Edwards Lifesciences (NYSE: EW) is the global leader in the science of heart
valves and hemodynamic monitoring. Driven by a passion to help patients, the
company partners with clinicians to develop innovative technologies in the
areas of structural heart disease and critical care monitoring that enable
them to save and enhance lives. In 2004, the company established The Edwards
Lifesciences Fund at the Vanguard Charitable Endowment Program to support
advancements in knowledge and improvements in quality-of-life, focusing
primarily upon cardiovascular disease and the communities where its employees
live and work. The Fund's mission is fulfilled by making grants to qualified
charitable organizations. Additional information about the company and its
Fund can be found at www.edwards.com.

(a) Source: American Heart Association, 2009

SOURCE Patient Advocate Foundation

Website: http://www.patientadvocate.org
Contact: Rebecca Reid, Schmidt Public Affairs, RReid@schmidtpa.com,
703-548-0019
 
Press spacebar to pause and continue. Press esc to stop.